Canaccord Genuity Remains a Buy on Atricure

FMR LLC grew its stake in shares of AtriCure by 2.7% in the first quarter. The stock is trading for about -10.64% less than its 52-week high. The SI to Atricure Incorporated's float is 8.12%.

AtriCure (NASDAQ ATRC) traded up 0.04% during mid-day trading on Friday, hitting $22.51.

AtriCure, Inc. (ATRC) remained successful in beating the consensus-estimated -$0.26 as it actually earned -$0.21 per share in its last reported financial results. (NASDAQ:ATRC) has risen 53.35% since October 9, 2016 and is uptrending. It has outperformed by 36.65% the S&P500.The move comes after 7 months negative chart setup for the $782.82 million company.

Compass Capital Management Inc increased Procter And Gamble Co (PG) stake by 2.98% reported in 2017Q2 SEC filing. Wellington Management Group LLP now owns 3,313,575 shares of the medical device company's stock worth $63,456,000 after acquiring an additional 176,025 shares during the last quarter. The value of the investment in AtriCure, Inc. went from $18,316,000 to $23,252,000 a change of $4,936,000 since the last quarter. Procter And Gamble Co now has $233.63B valuation.

As regular trading ended, Nektar Therapeutics (NKTR) stock brought in a -$0.92 drop to $23.89. It has underperformed by 9.16% the S&P500.

AtriCure, Inc., launched on October 31, 2000, is an atrial fibrillation (Afib) solutions company. Therefore 89% are positive.

The stock of AtriCure Inc. Leerink Swann restated an "outperform" rating and set a $26.00 target price on shares of AtriCure in a report on Friday, June 16th.

Among 9 analysts covering Atricure Inc. On Tuesday, October 6 the stock rating was maintained by Canaccord Genuity with "Buy". (NASDAQ:ATRC) is a huge mover today! Canaccord Genuity has "Buy" rating and $28.0 target. On Wednesday, October 28 the stock rating was maintained by Needham with "Buy". One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company's stock. The firm earned "Buy" rating on Tuesday, May 30 by Piper Jaffray.

ILLEGAL ACTIVITY WARNING: "AtriCure, Inc". Needham maintained AtriCure Inc. "(ATRC) Stock Rating Reaffirmed by Canaccord Genuity" was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. (NASDAQ:ATRC) has "Buy" rating given on Thursday, July 27 by Stifel Nicolaus. On Friday, November 4 the stock rating was maintained by Scotia Capital with "Outperform". The Company has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion.

In the latest earnings report the EPS was $-1.02 and is expected to be $-0.95 for the current year with 34,334,000 shares now outstanding. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures.

Since May 5, 2017, it had 0 insider purchases, and 3 sales for $1.68 million activity. Zacks Investment Research's earnings per share calculations are a mean average based on a survey of research firms that cover AtriCure. Hooven Michael D sold 10,000 shares worth $220,800.

Investors sentiment increased to 1.25 in Q2 2017. Its up 0.10, from 1.15 in 2017Q1. After $-0.21 actual earnings per share reported by AtriCure Inc. for the previous quarter, Wall Street now forecasts 14.29% negative EPS growth. Missouri-based Comm National Bank & Trust has invested 0% in AtriCure Inc. (NASDAQ:ATRC). Cortina Asset Management Limited Liability has 218,467 shares. The company has market cap of $804.79 million. Bancorp Of New York Mellon reported 0% in AtriCure Inc.

A number of equities analysts recently commented on ATRC shares. Point72 Asset Mngmt Lp has 0.02% invested in AtriCure Inc. Massachusetts Com Ma has invested 0% in AtriCure Inc. Northern Tru holds 427,560 shares. Axiom Invsts De stated it has 0.1% in AtriCure Inc. Deutsche Fincl Bank Ag holds 262,957 shares. 2,154 are held by Great West Life Assurance Company Can. (NASDAQ:ATRC). Macquarie Gru has invested 0% in AtriCure Inc. (NASDAQ:ATRC). 114,353 were reported by Adage Partners Gp Lc. Finally, Parametric Portfolio Associates LLC raised its stake in shares of AtriCure by 76.0% in the second quarter. 112 funds opened positions while 620 raised stakes. Lpl Fincl Ltd Limited Liability Company invested 0.27% of its portfolio in Procter & Gamble Co (NYSE:PG). Usa Portformulas Corp invested in 0.71% or 33,721 shares. State Board Of Administration Of Florida Retirement System holds 0% or 16,552 shares. State Street Corporation accumulated 617,405 shares. The first sale was made at $23.44 but later the stock became weaker, and closed with a fall of -4.01%.

Latest News